TRV
Third Rock Ventures Portfolio holdings
AUM
$1.07B
This Quarter Return
+52.86%
1 Year Return
+201.55%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$938M
AUM Growth
+$938M
(-23%)
Cap. Flow
-$607M
Cap. Flow
% of AUM
-64.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$344M |
| 2 |
BLUE
bluebird bio
BLUE
|
$111M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$95.8M |
| 4 |
Larimar Therapeutics
LRMR
|
$55.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1
DELISTED
Sage Therapeutics
SAGE
| $491M | 52.36% |
9,773,073
-1,907,935
| -16% | -$95.8M |
|
|
FMI
2
DELISTED
Foundation Medicine, Inc.
FMI
| $237M | 25.28% |
4,927,234
| – | – |
|
|
3
Larimar Therapeutics
LRMR
$310M
| $166M | 17.75% |
4,202,045
-1,400,000
| -25% | -$55.5M |
|
4
Carisma Therapeutics
CARM
$8.98M
| $43.2M | 4.61% |
4,841,591
| – | – |
|
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| – | – |
-3,070,090
| Closed | -$344M |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| – | – |
-1,215,054
| Closed | -$111M |
|